Bahrain and United Arab Emirates Offer Pfizer Shots as Boosters to People Vaccinated in China


Bahrain and the United Arab Emirates (UAE) are now calling on citizens who have been fully vaccinated with the COVID-19 vaccine made in China to be vaccinated with the Pfizer vaccine as a protective booster. At the same time, in Serbia, it is reported that 30% of elderly people vaccinated in China do not have antibodies.

This is due to the increase in post-vaccination deaths and miscarriages in China reported in Hong Kong over the past week.

The Chinese Communist Party administration will provide the COVID-19 vaccine made in China to countries in the Middle East, South America and Eastern Europe, despite the fact that Phase 3 trials have not been completed and clinical trial data have not been released. Has promoted “vaccine diplomacy” for the past year.

Serbia is the first European country to receive the COVID-19 vaccine manufactured by China’s state-owned company Sinopharm. According to the report by The Wall Street Journal According to the (WSJ), of the 150 vaccinated people with an average age of 65 years or older in the country, 29% did not have antibodies to the CCP virus 3 months after complete vaccination (double vaccination). Shown. Synofarm vaccine.

“The Sinopharm vaccine is not immunogenic and seems to have a particularly low impact on older recipients,” the doctor who led the study at the University of Belgrade told the journal.

The Epoch Times
Medical personnel administering Chinese-made Sinopharm vaccine to Serbian soldiers during a military COVID-19 vaccination operation in Belgrade on May 13, 2021. (Andrej Isakovic / AFP via Getty Images)

Chinese officials have previously stated that due to the lack of relevant clinical trial data, the Chinese COVID-19 vaccine is not allowed to be used in people over the age of 60 in China. However, in countries where the vaccine was purchased, older people can receive the vaccine preferentially.Taiwanese media He criticized China’s regime and said it was using people from the host country as experimental mice.

Despite the large number of citizens vaccinated against Sinopharm in both the UAE and Bahrain, COVID-19 infections are currently on the rise.

So far, 47% Bahrain population Are fully vaccinated and 60% are vaccinated against Sinopharm. However, the local epidemic has not slowed. The number of new infections per day has increased from 200 to 3,000 since the end of May, when vaccination began at the end of last year.

Bahrain currently has a record high number of confirmed cases, and since the end of May, authorities have provided Pfizer vaccine as a boost to those who have already been fully vaccinated with Sinopharm.

Bahrain’s health authorities are especially calling on vaccinated people 50 years and over, Obese people, or people with chronic illnesses inject Pfizer as a booster.

The UAE has made the Sinopharm vaccine available to the general public since December 2020 and has since offered a third dose of Sinopharm. march After it was discovered that the vaccine did not produce enough antibodies for some recipients.

In March, Gao Fu, director of the Chinese Center for Disease Control and Prevention, said in March that a third dose of the Chinese-made COVID-19 vaccine might be needed to increase efficacy.

The United Arab Emirates began using the Pfizer vaccine, which was created in collaboration with Germany’s BioNTech in April.

In addition to its low efficacy, serious side effects from Chinese vaccines have been reported.

In the last week of May, health officials Hong Kong Reported that 12 more people died after receiving the Sinovac vaccine, for a total of 80 deaths, while another 4 pregnant women had a miscarriage after the vaccination, bringing the total to 23.

Despite quality issues and lack of transparency in test data and side effects World Health Organization Recently approved both the Sinopharm and Sinovac vaccines for emergency use.